123 related articles for article (PubMed ID: 22199264)
1. L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.
Kaira K; Oriuchi N; Takahashi T; Nakagawa K; Ohde Y; Okumura T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
Anticancer Res; 2011 Dec; 31(12):4075-82. PubMed ID: 22199264
[TBL] [Abstract][Full Text] [Related]
2. LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer.
Kaira K; Oriuchi N; Takahashi T; Nakagawa K; Ohde Y; Okumura T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
Am J Transl Res; 2011; 3(5):468-78. PubMed ID: 22046488
[TBL] [Abstract][Full Text] [Related]
3. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Kaira K; Serizawa M; Koh Y; Takahashi T; Hanaoka H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Cancer; 2012 May; 48(8):1244-54. PubMed ID: 22330319
[TBL] [Abstract][Full Text] [Related]
4. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.
Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Oriuchi N; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
Anticancer Res; 2011 Nov; 31(11):3775-82. PubMed ID: 22110199
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract][Full Text] [Related]
7. Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumors.
Kaira K; Ohde Y; Endo M; Nakagawa K; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Kondo H; Nakajima T; Yamamoto N
Oncol Rep; 2011 Oct; 26(4):931-7. PubMed ID: 21750865
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).
Klabatsa A; Sheaff MT; Steele JP; Evans MT; Rudd RM; Fennell DA
Lung Cancer; 2006 Jan; 51(1):53-9. PubMed ID: 16169121
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Shimizu K; Tominaga H; Yanagitani N; Sunaga N; Ishizuka T; Nagamori S; Promchan K; Nakajima T; Yamamoto N; Mori M; Kanai Y
Anticancer Res; 2010 Dec; 30(12):4819-28. PubMed ID: 21187458
[TBL] [Abstract][Full Text] [Related]
10. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
11. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
[TBL] [Abstract][Full Text] [Related]
12. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma.
Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Kanai Y; Oyama T; Chikamatsu K
Pathol Oncol Res; 2013 Oct; 19(4):649-56. PubMed ID: 23516127
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway.
Goudarzi H; Iizasa H; Furuhashi M; Nakazawa S; Nakane R; Liang S; Hida Y; Yanagihara K; Kubo T; Nakagawa K; Kobayashi M; Irimura T; Hamada J
Cancer Lett; 2013 Oct; 339(1):82-92. PubMed ID: 23879962
[TBL] [Abstract][Full Text] [Related]
15. Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Cedrés S; Ponce-Aix S; Pardo-Aranda N; Navarro-Mendivil A; Martinez-Marti A; Zugazagoitia J; Sansano I; Montoro MA; Enguita A; Felip E
Lung Cancer; 2016 Jun; 96():1-6. PubMed ID: 27133741
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
Garland LL; Rankin C; Gandara DR; Rivkin SE; Scott KM; Nagle RB; Klein-Szanto AJ; Testa JR; Altomare DA; Borden EC
J Clin Oncol; 2007 Jun; 25(17):2406-13. PubMed ID: 17557954
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.
Kaira K; Sunose Y; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Segawa A; Furuya M; Mori M; Oyama T; Takeyoshi I
Br J Cancer; 2012 Aug; 107(4):632-8. PubMed ID: 22805328
[TBL] [Abstract][Full Text] [Related]
19. L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.
Yanagisawa N; Satoh T; Hana K; Ichinoe M; Nakada N; Endou H; Okayasu I; Murakumo Y
Cancer Biomark; 2015; 15(4):365-74. PubMed ID: 25835180
[TBL] [Abstract][Full Text] [Related]
20. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]